Xenon Pharmaceuticals Inc (XENE) Q3 2024 Earnings Call Highlights: Strategic Advancements and ... [Yahoo! Finance]
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.xenon-pharma.com
Company Research
Source: Yahoo! Finance
Cash Runway: Sufficient to fund operations into 2027. Release Date: November 12, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript Xenon Pharmaceuticals Inc ( NASDAQ:XENE ) has made significant progress in its clinical programs, particularly with its lead product, the Z2 Calendar, which is the only highly potent and selective KV7 potassium channel opener in clinical development for multiple indications. The company has robust long-term efficacy and safety data for the Z2 Calendar, with over 600 patient years of exposure in focal epilepsy patients, demonstrating impressive seizure freedom and improved quality of life. Xenon Pharmaceuticals Inc ( NASDAQ:XENE ) has a strong financial position with cash and cash equivalents of $803.3 million, expected to fund operations into 2027. The company is advancing its pipeline with multiple KV7 candidates and NAV 1.7 sodium channel inhibitors, aiming to file an IND or equivalent f
Show less
Read more
Impact Snapshot
Event Time:
XENE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XENE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XENE alerts
High impacting Xenon Pharmaceuticals Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
XENE
News
- Xenon to Present at Upcoming Investor Conferences [Canadian Business Journal (Canada)]Canadian Business Journal
- Xenon to Present at Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Xenon to Present at Upcoming Investor ConferencesGlobeNewswire
- Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus [Yahoo! Finance]Yahoo! Finance
- Xenon Pharmaceuticals Inc. (NASDAQ: XENE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $53.00 price target on the stock.MarketBeat
XENE
Earnings
- 11/12/24 - Beat
XENE
Sec Filings
- 11/12/24 - Form 10-Q
- 11/12/24 - Form 8-K
- 11/12/24 - Form SC
- XENE's page on the SEC website